Industry News
Study finds new moves in protein's evolution: Findings point to new approach to drug design
Oct 01, 2013
Highlighting an important but unexplored area of evolution, scientists at The Scripps Research Institute (TSRI) have found evidence that, over hundreds of millions of years, an essential protein has evolved chiefly by changing how it moves, rather than by changing its basic molecular structure... Read More
In advanced papillary kidney cancer, everolimus slows disease progression
Oct 01, 2013
The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease, according to research presented at the 2013 European Cancer Congress (ECC2013) [1]... Read More
The search for cancer genes could be aided by new survey of DNA alterations
Oct 01, 2013
Scanning the DNA of nearly 5,000 tumor samples, a team led by scientists at Dana-Farber Cancer Institute and the Broad Institute has identified 140 regions of scrambled genetic code believed to contain many undiscovered cancer genes... Read More
Cancer patients could benefit from the combining of Chinese and Western medicine
Oct 01, 2013
Combining traditional forms of Chinese and Western medicine could offer new hope for developing new treatments for liver, lung, colorectal cancers and osteosarcoma of the bones. Experts from Cardiff University's School of Medicine have joined forces with Peking University in China to test the health benefits of a traditional Chinese medicine... Read More
Focus on genomic signature of a tumor may lead to personalized therapy
Oct 01, 2013
Clinical trial design for new cancer therapies has historically been focused on the tissue of origin of a tumor, but a paper from researchers at Memorial Sloan-Kettering Cancer Center published in Nature Genetics supports a new approach: one based on the genomic signature of a tumor rather than the tissue of origin in the body... Read More
Tumor genetics, cancer cell signaling discoveries pave way for use of new therapies for thyroid cancer
Oct 01, 2013
For many years, patients with advanced thyroid cancer faced bleak prospects and no viable treatment options. But now, building on recent discoveries about the genetics and cell signaling pathways of thyroid tumors, researchers are developing exciting new weapons against the disease, using kinase inhibitors that target tumor cell division and blood vessels... Read More
The risk of developing and dying from breast and colon cancer increased by diabetes
Oct 01, 2013
Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them... Read More
The importance of telomere length in prostate cancer prognosis
Oct 01, 2013
Like the plastic caps at the end of shoelaces, telomeres protect - in their case - the interior-gene containing parts of chromosomes that carry a cell's instructional material... Read More
Progression of squamous cell carcinomas reduced in mice
Oct 01, 2013
The c-Fos oncogene has traditionally been linked to cellular activities related to cancer, such as cell division, differentiation - conversion from one cell type to another - or survival. Any alteration of these activities can set off the development of tumours, which has made c-Fos an important target for the understanding and treatment of cancer... Read More
Deadly form of lung cancer may be treatable with FDA-approved antidepressant
Oct 01, 2013
A little-used class of antidepressants appears potentially effective in combating a particularly deadly form of lung cancer, according to a new study from researchers at the Stanford University School of Medicine. And because the drugs have already been approved by the U.S... Read More
Previous Page Next Page